Skip to main content
Clinical Trials/NCT05630378
NCT05630378CompletedNot Applicable

Evaluation of a Multimodal Integrative Medicine and Naturopathy Program in an Outpatient Setting With Focus on Mind-Body Medicine and Mild Water-filtered Infrared-A Whole-body Hyperthermia for Improvement of Symptoms and Quality of Life in Patients With Post-COVID-19-syndrome - a Prospective Randomised Controlled Study -

Universität Duisburg-Essen1 site in 1 country42 target enrollmentStarted: May 11, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
42
Locations
1
Primary Endpoint
Fatigue - Change from week 0 to week 11

Study Overview

Brief Summary

The study aims to identify whether a multimodal integrative naturopathy outpatient clinical concept can improve the symptoms of patients suffering from post-COVID-Syndrome. Main outcome is fatigue. The outpatient clinical programme consists of 11 weeks wherein patients visit the clinic one day per week. The pillars of classical naturopathy are combined with extended naturopathy and complementary procedures. Previous naturopathical studies on patients with chronic fatigue syndrome could find numerous indications that different types of naturopathy can help patients with fatigue.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •18 to 75 years of age
  • •diagnosed with post covid syndrome
  • •fatigue with or without myalgia
  • •signed declaration of consent

Exclusion Criteria

  • •contraindications for whole body infrared hyperthermia (severe cardiovascular diseases, tumour diseases, acute infections, pregnant and breastfeeding women)
  • •Acute and or feverish microbially infections
  • •Pleuritic chest pain
  • •Relevant shortness of breath
  • •Zn Critical illness or intensive medical care because of COVID 19
  • •Patients with severe somatic, cardiovascular pneumological, rheumatic, endocrine or neurological comorbidities. Especially neurological disorders accompanied by cognitive impairment, severe liver or kidney disorders.
  • •Patients permanently treated with opioids, cannabis, immunosuppressive agents (e.g. corticoids, immunsuppressives) or alpha/beta-a(nta)gonists
  • •Patients with pain as a consequence of a severe psychiatric disease (bipolar disorder, psychosis, personality disorder, severe depression, substance abuse) as well as severe systematic disorders or neurological disorders
  • •Participation in other clinical studies

Arms & Interventions

Treatment group

Experimental

The treatment group has 11 visits in the outpatient clinic of integrative medicine and naturopathy. Additional they fill in a diary and wear a pedometer during the day. Diary and pedometer continue to week 15. In week 12 a video conference with the treatment-group takes place. During week 14+15 a qualitative telephone interview is set.

Patients fill in questionnaires before the start of the outpatient clinic and directly afterwards (week 11).

Intervention: outpatient clinic with multimodal integrative medicine and naturopathy for post-COVID-19 patients (Behavioral)

Waiting group

Other

Parallel to the treatment group the waiting group receives no intervention, but fills in a diary and wear a pedometer during the day. Their diary and pedometer continue only to week 11. No additional interventions (refresher; video conference; interview) take place. Patients fill in questionnaires before the start of the waiting phase, parallel to the start of the outpatient clinic and directly after its end (week 11).

Intervention: waiting group (Other)

Outcomes

Primary Outcomes

Fatigue - Change from week 0 to week 11

Time Frame: before start of intervention (week 0) and afterwards (week 11)

measured with MFI-20 questionnaire and Chalder fatigue scale MFI-20: 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Motivation and Reduced Activity. Higher total scores correspond with more acute levels of fatigue. Chalder fatigue scale: a questionnaire to measure the severity of tiredness in fatiguing illnesses. The 11-item chalder fatigue scale is often divided into two components: one that measures physical fatigue (questions 1-7) and one that measures mental fatigue (questions 8-11).

Secondary Outcomes

  • Sleep Quality(before start of intervention (week 0) and afterwards (week 11))
  • Hospital Anxiety and Depression(before start of intervention (week 0) and afterwards (week 11))
  • Quality of life 2(before start of intervention (week 0) and afterwards (week 11))
  • Quality of life 1(before start of intervention (week 0) and afterwards (week 11))
  • Perceived Stress(before start of intervention (week 0) and afterwards (week 11))
  • perceived Pain(before start of intervention (week 0) and afterwards (week 11))
  • Resilience(before start of intervention (week 0) and afterwards (week 11))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jost Langhorst

Univ.-Prof. Dr. med. (PhD, MD)

Universität Duisburg-Essen

Study Sites (1)

Loading locations...

Similar Trials

Evaluation of an Integrative Medicine... | Clinical Trial